Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02223650 · ClinicalTrials.gov registry record · NA
A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A NA study of Intermittent Exotropia, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 2
- Study locations
NCT02223650 is a NA study of Intermittent Exotropia that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 58 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02223650, a NA study of Intermittent Exotropia, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this short-term, pilot randomized trial comparing 2.50 diopters (D) overminus lens treatment vs. non-overminus (spectacles without overminus or no spectacles) in children with intermittent exotropia (IXT) 3 to \<7 years of age is to determine whether to proceed to a full-scale, longer-term randomized trial.
Conditions Studied
Interventions
- DEVICE Overminus treatment
- DEVICE Non-overminus treatment
Study Locations (2)
California
- Marshall B. Ketchum University - Fullerton
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02223650
The ClinicalTrials.gov registry entry for NCT02223650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intermittent Exotropia appearing as the primary indexed condition, and to 2 interventions - of which Overminus treatment is the first listed.
NCT02223650 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02223650 about?
NCT02223650 is a clinical study titled "A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia". The objective of this short-term, pilot randomized trial comparing 2.50 diopters (D) overminus lens treatment vs. non-overminus (spectacles without overminus or no spectacles) in children with intermittent exotropia (IXT) 3 to \<7 years of age is to determine whether to proceed to a full-scale, long...
What is the current status of trial NCT02223650?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2014-12. Estimated completion is 2015-07.
What conditions does trial NCT02223650 study?
This clinical trial studies the following conditions: Intermittent Exotropia.
What interventions are being tested in trial NCT02223650?
The interventions under investigation include: Overminus treatment (DEVICE), Non-overminus treatment (DEVICE).
Who is sponsoring clinical trial NCT02223650?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02223650 being conducted?
This trial has 2 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intermittent Exotropia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.